(Q38113139)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749084%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Wnt and lithium: a common destiny in the therapy of nervous system pathologies? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749084%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749084%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Mehrnaz Jafarian-Tehrani

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749084%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Delphine Meffre

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749084%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Julien Grenier

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749084%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Sophie Bernard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749084%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Françoise Courtin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749084%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Ghjuvan'Ghjacumu Shackleford

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749084%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Charbel Massaad

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749084%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

1 reference

9 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749084%20AND%20SRC:MED&resulttype=core&format=json

Cellular and Molecular Life Sciences

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749084%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749084%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749084%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

1123-1148

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749084%20AND%20SRC:MED&resulttype=core&format=json

WNTs in the vertebrate nervous system: from patterning to neuronal connectivity

2 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Wnt signaling in vertebrate neural development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

GSK-3 and Wnt Signaling in Neurogenesis and Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Crooked tail (Cd) model of human folate-responsive neural tube defects is mutated in Wnt coreceptor lipoprotein receptor-related protein 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Wnt signaling through Dishevelled, Rac and JNK regulates dendritic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Regulation of NMDA-receptor synaptic transmission by Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Wnt signaling during synaptic development and plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Emerging roles of Wnts in the adult nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Wnt/beta-catenin signaling is an essential and direct driver of myelin gene expression and myelinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium enhances remyelination of peripheral nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Genome-wide analysis of a Wnt1-regulated transcriptional network implicates neurodegenerative pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

GSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Morphogens and pattern formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Identification of distinct classes and functional domains of Wnts through expression of wild-type and chimeric proteins in Xenopus embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Selective activation mechanisms of Wnt signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Wnt and calcium signaling: beta-catenin-independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

A quest for the mechanism regulating global planar cell polarity of tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Wnt signalling: variety at the core.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

beta-catenin is a target for the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Transcription under the control of nuclear Arm/beta-catenin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Protein phosphatase 1 regulates assembly and function of the beta-catenin degradation complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

beta-catenin can be transported into the nucleus in a Ran-unassisted manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Specific armadillo repeat sequences facilitate β-catenin nuclear transport in live cells via direct binding to nucleoporins Nup62, Nup153, and RanBP2/Nup358.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Rac1 activation controls nuclear localization of beta-catenin during canonical Wnt signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with beta-catenin/Armadillo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

The chromatin-remodeling enzyme BRG1 modulates vascular Wnt signaling at two levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Histone H4 Lys 20 monomethylation by histone methylase SET8 mediates Wnt target gene activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Dishevelled activates Ca2+ flux, PKC, and CamKII in vertebrate embryos.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Diversin regulates heart formation and gastrulation movements in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Prickle mediates feedback amplification to generate asymmetric planar cell polarity signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Regulation of planar cell polarity by Smurf ubiquitin ligases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Dishevelled-1 regulates microtubule stability: a new function mediated by glycogen synthase kinase-3beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Mechanism of activation of the Formin protein Daam1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Wnt/Frizzled activation of Rho regulates vertebrate gastrulation and requires a novel Formin homology protein Daam1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Formin proteins of the DAAM subfamily play a role during axon growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

JNK1 Is Required for Maintenance of Neuronal Microtubules and Controls Phosphorylation of Microtubule-Associated Proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

c-Jun N-terminal kinase (JNK) cooperates with Gsk3beta to regulate Dishevelled-mediated microtubule stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Dishevelled promotes axon differentiation by regulating atypical protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

aPKC acts upstream of PAR-1b in both the establishment and maintenance of mammalian epithelial polarity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Wnt signaling in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Modulation of the microtubule cytoskeleton: a role for a divergent canonical Wnt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Wnts: up-and-coming at the synapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Inactivation of glycogen synthase kinase 3 promotes axonal growth and recovery in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Wnt signaling in axon guidance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Phosphatidylinositol-3-kinase-atypical protein kinase C signaling is required for Wnt attraction and anterior-posterior axon guidance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Wnt signaling inhibitors regulate the transcriptional response to morphogenetic Shh-Gli signaling in the neural tube

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

The posteriorizing gene Gbx2 is a direct target of Wnt signalling and the earliest factor in neural crest induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Wnt signaling is required at distinct stages of development for the induction of the posterior forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Wnt1-lmx1a forms a novel autoregulatory loop and controls midbrain dopaminergic differentiation synergistically with the SHH-FoxA2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Wnt-mediated down-regulation of Sp1 target genes by a transcriptional repressor Sp5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

The Wnt/beta-catenin pathway directs neuronal differentiation of cortical neural precursor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium enhances the neuronal differentiation of neural progenitor cells in vitro and after transplantation into the avulsed ventral horn of adult rats through the secretion of brain-derived neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Wnt-mediated activation of NeuroD1 and retro-elements during adult neurogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

LEF1/beta-catenin complex regulates transcription of the Cav3.1 calcium channel gene (Cacna1g) in thalamic neurons of the adult brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Involvement of {beta}-catenin and unusual behavior of CBP and p300 in glucocorticosteroid signaling in Schwann cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Induction of the Wnt antagonist Dickkopf-1 is involved in stress-induced hippocampal damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Glucocorticoids and lithium reciprocally regulate the proliferation of adult dentate gyrus-derived neural precursor cells through GSK-3beta and beta-catenin/TCF pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Thyroid hormone receptors in brain development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Role of late maternal thyroid hormones in cerebral cortex development: an experimental model for human prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

The thyroid-brain interaction in thyroid disorders and mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Recovery from chronic demyelination by thyroid hormone therapy: myelinogenesis induction and assessment by diffusion tensor magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Thyroid hormone signaling acts as a neurogenic switch by repressing Sox2 in the adult neural stem cell niche.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Thyroid hormone deiodinases in the central and peripheral nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Thyroid hormone and the neuroglia: both source and target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Thyroid hormones and the control of cell proliferation or cell differentiation: paradox or duality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Beta-catenin/Tcf-1-mediated transactivation of cyclin D1 promoter is negatively regulated by thyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Regulation of beta-catenin by a novel nongenomic action of thyroid hormone beta receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Retracted: Multi-Level Interactions between the Nuclear Receptor TRα1 and the WNT Effectors β-Catenin/Tcf4 in the Intestinal Epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Thyroid hormone-mediated growth and differentiation of growth plate chondrocytes involves IGF-1 modulation of beta-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Advanced bone formation in mice with a dominant-negative mutation in the thyroid hormone receptor β gene due to activation of Wnt/β-catenin protein signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Dickkopf 4 positively regulated by the thyroid hormone receptor suppresses cell invasion in human hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Silencing of Wnt signaling and activation of multiple metabolic pathways in response to thyroid hormone-stimulated cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Oligodendrocyte maturation and progenitor cell proliferation are independently regulated by thyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

SRY-box containing gene 17 regulates the Wnt/β-catenin signaling pathway in oligodendrocyte progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Oxysterol biosynthetic enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Changes in human plasma levels of the brain specific oxysterol 24S-hydroxycholesterol during progression of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Decreased levels of the brain specific 24S-hydroxycholesterol and cholesterol precursors in serum of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

25-hydroxycholesterol provokes oligodendrocyte cell line apoptosis and stimulates the secreted phospholipase A2 type IIA via LXR beta and PXR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

A transcriptional co-repressor that interacts with nuclear hormone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Role of p160 coactivator complex in the activation of liver X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Inactivation of liver X receptor beta leads to adult-onset motor neuron degeneration in male mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Interplay between LXR and Wnt/β-catenin signaling in the negative regulation of peripheral myelin genes by oxysterols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Modulation of liver X receptor signaling as a prevention and therapy for colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Suppression of beta-catenin signaling by liver X receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium normalizes elevated intracellular sodium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Potentiation of antidepressant-like activity with lithium: mechanism involved

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Is competition between Li+ and Mg2+ the underlying theme in the proposed mechanisms for the pharmacological action of lithium salts in bipolar disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium inhibits glycogen synthase kinase-3 by competition for magnesium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Determination of the lithium binding site in inositol monophosphatase, the putative target for lithium therapy, by magic-angle-spinning solid-state NMR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Chemical and kinetic mechanism of the inositol monophosphatase reaction and its inhibition by Li+.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Competition between Li+ and Mg2+ in metalloproteins. Implications for lithium therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Dissection of the difference between the group I metal ions in inhibiting GSK3β: a computational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Wnt7a signaling promotes dendritic spine growth and synaptic strength through Ca²⁺/Calmodulin-dependent protein kinase II

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

β-catenin is critical for dendritic morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Akt/GSK3 signaling in the action of psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Deletion of GSK3β in D2R-expressing neurons reveals distinct roles for β-arrestin signaling in antipsychotic and lithium action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

A kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium prevents excitotoxic cell death of motoneurons in organotypic slice cultures of spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Chronic lithium treatment antagonizes glutamate-induced decrease of phosphorylated CREB in neurons via reducing protein phosphatase 1 and increasing MEK activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

The cholinergic basal forebrain system during development and its influence on cognitive processes: important questions and potential answers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

The role of the α7 nicotinic receptor in cognitive processing of persons with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Hippocampal α7 nicotinic acetylcholine receptor levels in patients with schizophrenia, bipolar disorder, or major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Muscarinic acetylcholine receptors as CNS drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Wnt-7a induces presynaptic colocalization of alpha 7-nicotinic acetylcholine receptors and adenomatous polyposis coli in hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Wnt signaling regulates acetylcholine receptor translocation and synaptic plasticity in the adult nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Pharmacological inhibition of GSK3 attenuates DNA damage-induced apoptosis via reduction of p53 mitochondrial translocation and Bax oligomerization in neuroblastoma SH-SY5Y cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Regulatory effect of lithium on thyroxine metabolism in murine neural and anterior pituitary tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Effects of lithium and carbamazepine on thyroid hormone metabolism in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Thyroid hormones in the rat amygdala as common targets for antidepressant drugs, mood stabilizers, and sleep deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium administration affects gene expression of thyroid hormone receptors in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Differential expression of thyroid hormone receptor isoforms by thyroid hormone and lithium in rat GH3 and B103 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Greater cortical gray matter density in lithium-treated patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

In search of the Holy Grail for the treatment of neurodegenerative disorders: has a simple cation been overlooked?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lentivirally mediated GSK-3β silencing in the hippocampal dentate gyrus induces antidepressant-like effects in stressed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Beta-catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

A schizophrenia-linked mutation in PIP5K2A fails to activate neuronal M channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Control of neuronal ion channel function by glycogen synthase kinase-3: new prospective for an old kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Glycogen synthase kinase 3beta as a likely target for the action of lithium on circadian clocks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Identification of a glycogen synthase kinase-3β inhibitor that attenuates hyperactivity in CLOCK mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

The Frizzled 3 gene is associated with methamphetamine psychosis in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Schizophrenia as a GSK-3 dysregulation disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Positional pathway screen of wnt signaling genes in schizophrenia: association with DKK4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

The tumor suppressor adenomatous polyposis coli gene is associated with susceptibility to schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Low GSK-3beta in schizophrenia as a consequence of neurodevelopmental insult

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Combination therapy in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

DISC1 at 10: connecting psychiatric genetics and neuroscience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Schizophrenia and affective disorders--cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Interplay between DISC1 and GABA signaling regulates neurogenesis in mice and risk for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Disrupted-in-Schizophrenia 1 (DISC1) is necessary for the correct migration of cortical interneurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Dixdc1 is a critical regulator of DISC1 and embryonic cortical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Abnormal behavior in mice mutant for the Disc1 binding partner, Dixdc1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Molecular basis of Wnt activation via the DIX domain protein Ccd1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

DISC1 regulates synaptic vesicle transport via a lithium-sensitive pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

MiR-16 Targets the Serotonin Transporter: A New Facet for Adaptive Responses to Antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Raphe-mediated signals control the hippocampal response to SRI antidepressants via miR-16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium inhibits amyloid secretion in COS7 cells transfected with amyloid precursor protein C100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Modulation of GSK-3 as a Therapeutic Strategy on Tau Pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium down-regulates tau in cultured cortical neurons: a possible mechanism of neuroprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium, but not valproate, induces the serine/threonine phosphatase activity of protein phosphatase 2A in the rat brain, without affecting its expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Frizzled-1 is involved in the neuroprotective effect of Wnt3a against Abeta oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Amyloid-beta binds to the extracellular cysteine-rich domain of Frizzled and inhibits Wnt/beta-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Inhibition of Wnt signaling, modulation of Tau phosphorylation and induction of neuronal cell death by DKK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

The secreted Wnt antagonist Dickkopf-1 is required for amyloid β-mediated synaptic loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

M1 receptors play a central role in modulating AD-like pathology in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Huperzine A activates Wnt/β-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

The anti-inflammatory and cholinesterase inhibitor bifunctional compound IBU-PO protects from beta-amyloid neurotoxicity by acting on Wnt signaling components.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal β-catenin pathway function in an Alzheimer's disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium and dementia: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium treatment and risk of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

A feasibility and tolerability study of lithium in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

The GSK3 hypothesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium rescues toxicity of aggregate-prone proteins in Drosophila by perturbing Wnt pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Glycogen synthase kinase-3beta inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Evidence of calpain/cdk5 pathway inhibition by lithium in 3-nitropropionic acid toxicity in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Mutant huntingtin-impaired degradation of beta-catenin causes neurotoxicity in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Chronic lithium chloride treatment has variable effects on motor behaviour and survival of mice transgenic for the Huntington's disease mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

NP03, a novel low-dose lithium formulation, is neuroprotective in the YAC128 mouse model of Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Differential fate and functional outcome of lithium chloride primed adult neural progenitor cell transplants in a rat model of Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

The importance of Wnt signalling for neurodegeneration in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3beta and attenuated by lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Inhibition of glycogen synthase kinase-3 reduces L-DOPA-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Plasticity of subventricular zone neuroprogenitors in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of Parkinson's disease involves cross talk between inflammatory and Wnt/β-catenin signaling pathways: functional consequences for n

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and Bax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium and oxidative stress lessons from the MPTP model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium protects against oxidative stress-mediated cell death in α-synuclein-overexpressing in vitro and in vivo models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Potential autophagy enhancers attenuate rotenone-induced toxicity in SH-SY5Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium fails to protect dopaminergic neurons in the 6-OHDA model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Disabling parkinsonism due to lithium: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Blockade of acute microglial activation by minocycline promotes neuroprotection and reduces locomotor hyperactivity after closed head injury in mice: a twelve-week follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Minocycline restores olfactory bulb volume and olfactory behavior after traumatic brain injury in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Minocycline restores sAPPα levels and reduces the late histopathological consequences of traumatic brain injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Evaluation of late cognitive impairment and anxiety states following traumatic brain injury in mice: the effect of minocycline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Multifunctional drugs for head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Role of glycogen synthase kinase-3beta in early depressive behavior induced by mild traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Neuroprotective effect and cognitive outcome of chronic lithium on traumatic brain injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium ameliorates neurodegeneration, suppresses neuroinflammation, and improves behavioral performance in a mouse model of traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium reduces BACE1 overexpression, β amyloid accumulation, and spatial learning deficits in mice with traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Involvement of the glycogen synthase kinase-3 signaling pathway in TBI pathology and neurocognitive outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

The role of pharmacotherapy in the management of behaviour disorders in traumatic brain injury patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Inhibition of experimental allergic encephalomyelitis by lithium chloride: specific effect or nonspecific stress?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium prevents and ameliorates experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

GSK3β genetic variability in patients with Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Canavan disease: a white matter disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

The effects of lithium chloride and other substances on levels of brain N-acetyl-L-aspartic acid in Canavan disease-like rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium citrate for Canavan disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium citrate as treatment of Canavan disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Tract-specific white matter structural disruption in patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium and GSK3-β promoter gene variants influence white matter microstructure in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

The syndrome of irreversible lithium-effectuated neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium stimulates progenitor proliferation in cultured brain neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium restores neurogenesis in the subventricular zone of the Ts65Dn mouse, a model for Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Lithium regulates hippocampal neurogenesis by ERK pathway and facilitates recovery of spatial learning and memory in rats after transient global cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

MicroRNA-134 plasma levels before and after treatment for bipolar mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Casein kinase I phosphorylates the Armadillo protein and induces its degradation in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Cell cycle control of wnt receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Regulation of phosphatidylinositol kinases and metabolism by Wnt3a and Dvl

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

RGS19 regulates Wnt-beta-catenin signaling through inactivation of Galpha(o).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

The trimeric G protein Go inflicts a double impact on axin in the Wnt/frizzled signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Negative feedback regulation of Wnt signaling by Gbetagamma-mediated reduction of Dishevelled

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Nuclear Dvl, c-Jun, beta-catenin, and TCF form a complex leading to stabilization of beta-catenin-TCF interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Wingless signaling induces widespread chromatin remodeling of target loci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

The DIX domain targets dishevelled to actin stress fibres and vesicular membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

GSK3β negatively regulates oligodendrocyte differentiation and myelination in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1378-1

Antiapoptotic action of lithium and valproate.

21 January 2018

1 reference

12 December 2020

Thyroid hormone's action on progenitor/stem cell biology: new challenge for a classic hormone?

1 reference

12 December 2020

Pygopus, a nuclear PHD-finger protein required for Wingless signaling in Drosophila

1 reference

12 December 2020

β-Catenin regulates deiodinase levels and thyroid hormone signaling in colon cancer cells

1 reference

12 December 2020

SnapShot: Noncanonical Wnt Signaling Pathways

1 reference

12 December 2020

Induction of Dickkopf-1 contributes to the neurotoxicity of MPP+ in PC12 cells via inhibition of the canonical Wnt signaling pathway

1 reference

12 December 2020

Lithium combined with neuroleptics in chronic schizophrenic and schizoaffective patients

1 reference

12 December 2020

Proximal events in Wnt signal transduction

1 reference

12 December 2020

Interneuron dysfunction in psychiatric disorders

1 reference

12 December 2020

Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death

1 reference

12 December 2020

Tau phosphorylation and neuronal apoptosis induced by the blockade of PP2A preferentially involve GSK3β

1 reference

12 December 2020

Effect of Oxysterol Treatment on Cholesterol Biosynthesis and Reactive Astrocyte Proliferation in Injured Rat Brain Cortex

1 reference

12 December 2020

A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical, pharmacokinetic, and pharmacogenetic investigation

1 reference

12 December 2020

Enhancement of hippocampal neurogenesis by lithium

1 reference

12 December 2020

pygopus Encodes a nuclear protein essential for wingless/Wnt signaling

1 reference

12 December 2020

Lithium enhances long‐term potentiation independently of hippocampal neurogenesis in the rat dentate gyrus

1 reference

12 December 2020

Effects of pharmacological and nonpharmacological treatments on thyroid hormone metabolism and concentrations in rat brain

1 reference

12 December 2020

Glycogen synthase kinase 3β gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium.

1 reference

12 December 2020

Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder

1 reference

12 December 2020

Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model.

1 reference

12 December 2020

Thyroid hormone receptor activity in the absence of ligand: physiological and developmental implications.

1 reference

12 December 2020

Increase inGSK3β gene copy number variation in bipolar disorder

1 reference

12 December 2020

MicroRNAs in cancers and neurodegenerative disorders

1 reference

12 December 2020

1 reference

12 December 2020

Wnt signaling is sufficient to perturb oligodendrocyte maturation

1 reference

12 December 2020

A mitogen gradient of dorsal midline Wnts organizes growth in the CNS

1 reference

12 December 2020

[Thyroid hormones and maturation of the nervous system]

1 reference

12 December 2020

A morphogen gradient of Wnt/beta-catenin signalling regulates anteroposterior neural patterning in Xenopus.

1 reference

12 December 2020

M1 muscarinic receptor activation protects neurons from beta-amyloid toxicity. A role for Wnt signaling pathway

1 reference

12 December 2020

Role of thyroid hormones and their receptors in peripheral nerve regeneration

1 reference

12 December 2020

Novel functions for small RNA molecules

1 reference

12 December 2020

Therapeutic effects of valproate combined with lithium carbonate on MPTP-induced parkinsonism in mice: possible mediation through enhanced autophagy

1 reference

12 December 2020

GSK3 Function in the Brain during Development, Neuronal Plasticity, and Neurodegeneration

1 reference

12 December 2020

Differential regulation of Wnt/beta-catenin signaling by Liver X Receptors in Schwann cells and oligodendrocytes

1 reference

12 December 2020

Adult neural stem cell cycling in vivo requires thyroid hormone and its alpha receptor

1 reference

12 December 2020

Etazolate, an α-secretase activator, reduces neuroinflammation and offers persistent neuroprotection following traumatic brain injury in mice.

1 reference

12 December 2020

Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances

1 reference

12 December 2020

More good news about the magic ion: lithium may prevent dementia

1 reference

12 December 2020

A Drosophila Axin homolog, Daxin, inhibits Wnt signaling

1 reference

12 December 2020